Skip to Main Content

Paper Details

Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells.
Am J Clin Exp Urol
12
2019
Author NameAffiliation
Christopher P EvansUniversity of California Davis CA
Christopher P EvansUC Davis Comprehensive Cancer Center, University of California Davis CA
  • 1 - 2

Datasets

Release 1.2